IMMUNOREGULATORY ROLE OF INTERLEUKIN-10 IN PATIENTS WITH INFLAMMATORY BOWEL-DISEASE

被引:380
作者
SCHREIBER, S
HEINIG, T
THIELE, HG
RAEDLER, A
机构
[1] UNIV HAMBURG, GASTROENTEROL SECT, HAMBURG, GERMANY
[2] UNIV HAMBURG, DEPT MED, DEPT IMMUNOL, HAMBURG, GERMANY
关键词
D O I
10.1016/0016-5085(95)90692-4
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background/Aims: Active inflammatory bowel disease (IBD) is associated with increased proinflammatory cytokines. Deficiency of interleukin (IL) 10, a contrainflammatory cytokine, leads to the development of colitis in IL-10 knockout mice. We characterized IL-10 regulation of proinflammatory cytokine (tumor necrosis factor [TNF] alpha and IL-1 beta) expression in IBD in vitro and in vivo. Methods: IL-10 regulation of IL-1 beta, TNF-alpha, and IL-1 receptor antagonist expression by peripheral monocytes or isolated lamina propria mononuclear cells (LPMNC), respectively, was studied by enzyme-linked immunosorbent assay (cytokine secretion) and by semiquantitative reverse-transcription polymerase chain reaction. Results: IL-10 down-regulates IL-1 beta and TNF-alpha secretion as well as messenger RNA levels in IBD peripheral monocytes and LPMNC in a dose-dependent manner. In parallel, IL-1 receptor antagonist secretion is induced, and IL-10 can restore diminished in vitro IL-1 receptor antagonist/IL-1 beta ratios in IBD to normal levels. Equal concentrations of IL-10 are detectable in both normal and IBD intestinal lamina propria biopsy homogenates. After topical IL-10 enema treatment of three steroid therapy-refractory patients with ulcerative colitis, in vitro release of proinflammatory cytokines from IBD peripheral monocytes as well as LPMNC is dramatically down-regulated. Conclusions: IL-10 down-regulates the enhanced secretion as well as messenger RNA levels of proinflammatory cytokines by IBD mononuclear phagocytes in vitro. In vivo topical application of IL-10 induces down-regulation of proinflammatory cytokine secretion both systemically and locally.
引用
收藏
页码:1434 / 1444
页数:11
相关论文
共 40 条
[1]  
Pallone, Fais, Squarcia, Biancone, Pozilli, Boivirant, Activation of peripheral blood and intestinal lymphocytes in Crohn's disease, In vivo state of activation and in vitro response to stimulation as defined by the expression of early activation antigens, 28, pp. 745-753, (1987)
[2]  
Mahida, Wu, Jewell, Enhanced production of interleukin 1-β by mononuclear cells isolated from mucosa with active ulcerative colitis or Crohn's disease, Gut, 30, pp. 835-838, (1989)
[3]  
Ligumsky, Simon, Karmeli, Rachmilewitz, Role of interleukin 1 in inflammatory bowel disease—enhanced production during active disease, Gut, 31, pp. 686-689, (1990)
[4]  
MacDonald, Hutchings, Choy, Murch, Cooke, Tumour necrosis factor-alpha and interferon-gamma production measured at the single cell level in normal and inflamed human intestine, Clin Exp Immunol, 81, pp. 301-305, (1990)
[5]  
Schreiber, MacDermott, Raedler, Pinnau, Bertovich, Nash, Increased activation of intestinal lamina propria mononuclear cells in inflammatory bowel disease, Gastroenterology, 101, pp. 1020-1030, (1991)
[6]  
Reinecker, Steffen, Witthoeft, Pflueger, Schreiber, MacDermott, Raedler, Enhanced secretion of tumor necrosis factor-alpha, IL-6, and IL-1 beta by isolated lamina propria mononuclear cells from patients with ulcerative colitis and Crohn's disease, Clin Exp Immunol, 94, pp. 174-181, (1993)
[7]  
Brynskov, Tvede, Andersen, Vilien, Increased concentrations of interleukin 1β, interleukin 2, and soluble interleukin-2 receptors in endoscopic mucosal biopsy specimens with active inflammatory bowel disease, Gut, 33, pp. 55-58, (1992)
[8]  
Pullman, Elsbury, Masanobu, Hapel, Doe, Enhanced mucosal cytokine production in inflammatory bowel disease, Gastroenterology, 102, pp. 529-537, (1992)
[9]  
Mullin, Lazenby, Harris, Bayless, James, Increased interleukin 2 messenger RNA in the intestinal mucosal lesions of Crohn's disease but not ulcerative colitis, Gastroenterology, 102, pp. 1620-1627, (1992)
[10]  
Schreiber, Raedler, Conn, Rombeau, MacDermott, Increased release of soluble interleukin-2 receptor by colonic lamina propria mononuclear cells in inflammatory bowel disease, Gut, 32, pp. 236-239, (1992)